# 2O IMpower010: Biomarkers of disease-free survival (DFS) in a phase III study of atezolizumab (atezo) vs best supportive care (BSC) after adjuvant chemotherapy in stage IB-IIIA NSCLC

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/2o-impower010-biomarkers-of-disease-free-survival-dfs-in-a-phase-iii-study-of/

## Facts

| Field | Value |
| --- | --- |
| Author Names | C. Zhou,Meghna Das Thakur,Manoj Srivastava,Wen Zou,Hongjie Xu,M. Ballinger,Enriqueta Felip,Heather A. Wakelee,Nasser K. Altorki,Martin Reck,Rüediger Liersch,Anna Kryzhanivska,M. Harada,Hiroshi Tanaka,John Hamm,Steve McCune,Virginia McNally,Elizabeth Bennett,Barbara J. Gitlitz,Silvia Novello |
| Citations | 76 |
| DOI | 10.1016/j.annonc.2021.10.018 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W4200147408 |
| Type | article |
| Year | 2021 |

## Paper authors

- [C. Zhou](https://scholariq.org/researchers/c-zhou/)

## Paper journal

- [Annals of Oncology](https://scholariq.org/journals/annals-of-oncology/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.